Class information for:
Level 2: RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
701 12232 35.1 72%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
196 49095 NUCL MED//RADIOIMMUNOTHERAPY//JOURNAL OF NUCLEAR MEDICINE

Classes in level below (level 1)


ID, lev. below Publications Label for level below
574 3206 ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//RADIOIMMUNOGUIDED SURGERY//IMMUNOSCINTIGRAPHY
4884 1638 RADIOIMMUNOTHERAPY//PRETARGETING//Y 90 IBRITUMOMAB TIUXETAN
9979 1038 ANTI IDIOTYPIC ANTIBODY//ANTI ANTI IDIOTYPIC ANTIBODY//INTERNAL IMAGE
10436 997 BISPECIFIC ANTIBODIES//CATUMAXOMAB//TRIFUNCTIONAL ANTIBODY
11217 933 AT 211//TARGETED ALPHA THERAPY//BI 213
11379 919 AFFIBODY MOLECULE//AFFIBODY MOLECULES//AFFIBODY
12231 857 POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700
14311 712 IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG
14504 699 EP CAM//TROP2//EDRECOLOMAB
15060 664 AUGER ELECTRONS//AUGER ELECTRON EMITTER//CELLULAR DOSIMETRY
22363 328 EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI
30983 130 GIRENTUXIMAB//G250//MONOCLONAL ANTIBODY CG250
32232 111 UNIT OTOLARYNGOL HEAD NECK SURG//E48//BIOMED RADIAT

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RADIOIMMUNOTHERAPY Author keyword 1251 75% 7% 907
2 BISPECIFIC ANTIBODIES Author keyword 281 63% 2% 284
3 EP CAM Author keyword 122 53% 1% 160
4 PRETARGETING Author keyword 115 72% 1% 91
5 ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS Journal 110 65% 1% 106
6 AT 211 Author keyword 102 89% 0% 47
7 AFFIBODY MOLECULE Author keyword 89 84% 0% 48
8 UNIT BIOMED RADIAT SCI Address 72 70% 0% 60
9 TARGETED ALPHA THERAPY Author keyword 67 87% 0% 33
10 ASTATINE 211 Author keyword 63 83% 0% 35

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 RADIOIMMUNOTHERAPY 1251 75% 7% 907 Search RADIOIMMUNOTHERAPY Search RADIOIMMUNOTHERAPY
2 BISPECIFIC ANTIBODIES 281 63% 2% 284 Search BISPECIFIC+ANTIBODIES Search BISPECIFIC+ANTIBODIES
3 EP CAM 122 53% 1% 160 Search EP+CAM Search EP+CAM
4 PRETARGETING 115 72% 1% 91 Search PRETARGETING Search PRETARGETING
5 AT 211 102 89% 0% 47 Search AT+211 Search AT+211
6 AFFIBODY MOLECULE 89 84% 0% 48 Search AFFIBODY+MOLECULE Search AFFIBODY+MOLECULE
7 TARGETED ALPHA THERAPY 67 87% 0% 33 Search TARGETED+ALPHA+THERAPY Search TARGETED+ALPHA+THERAPY
8 ASTATINE 211 63 83% 0% 35 Search ASTATINE+211 Search ASTATINE+211
9 AFFIBODY MOLECULES 62 90% 0% 27 Search AFFIBODY+MOLECULES Search AFFIBODY+MOLECULES
10 RADIOIMMUNODETECTION 60 57% 1% 71 Search RADIOIMMUNODETECTION Search RADIOIMMUNODETECTION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 RADIOIMMUNOTHERAPY 1035 61% 9% 1089
2 RADIOIMMUNODETECTION 210 76% 1% 149
3 IMMUNOSCINTIGRAPHY 193 61% 2% 207
4 RADIOLABELED ANTIBODIES 190 71% 1% 154
5 EP CAM 166 52% 2% 225
6 B723 160 70% 1% 131
7 RADIOTOXICITY 148 68% 1% 130
8 BISPECIFIC ANTIBODIES 129 43% 2% 228
9 HYBRID HYBRIDOMAS 127 80% 1% 78
10 IODINE I 131 TOSITUMOMAB 110 70% 1% 92

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS 110 65% 1% 106
2 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 58 19% 2% 268
3 NUCLEAR MEDICINE AND BIOLOGY 51 12% 3% 412
4 NUCLEAR MEDICINE-NUKLEARMEDIZIN 5 25% 0% 16

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Epithelial cell adhesion molecule expression (CD326) in cancer: A short review 2012 87 45 60%
Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications 2010 146 87 76%
Bispecific T-cell engagers for cancer immunotherapy 2015 2 46 72%
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy 2006 172 91 88%
Epithelial cell adhesion molecule - More than a carcinoma marker and adhesion molecule 2007 186 70 67%
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling 2009 157 17 65%
Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy 2015 3 124 37%
DARPins and other repeat protein scaffolds: advances in engineering and applications 2011 61 76 64%
Alternative binding proteins: Affibody binding proteins developed from a small three-helix bundle scaffold 2008 117 56 75%
Radioimmunotherapy with alpha-emitting nuclides 1998 191 41 93%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 UNIT BIOMED RADIAT SCI 72 70% 0.5% 60
2 BIOMED RADIAT SCI 59 50% 0.7% 85
3 RADIOIMMUNE INORGAN CHEM SECT 45 46% 0.6% 73
4 GARDEN STATE CANC 38 51% 0.4% 52
5 MOL MED IMMUNOL 37 49% 0.5% 56
6 PRECLIN PET PLATFORM 20 49% 0.2% 29
7 RADIAT ONCOL BRANCH 17 16% 0.8% 101
8 PHILOCHEM AG 17 63% 0.1% 17
9 SECT RADIODIAG THER Y 15 82% 0.1% 9
10 RADIAT ONCOL RADIAT 13 80% 0.1% 8

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000020129 PHAGE DISPLAY//CATALYTIC ANTIBODIES//CATALYTIC ANTIBODY
2 0.0000019009 EXCITATION FUNCTIONS//INTEGRAL YIELD//RADIATION SYNOVECTOMY
3 0.0000017551 REG PROTEIN//PANCREATITIS ASSOCIATED PROTEIN//NEURONAL THREAD PROTEIN
4 0.0000014789 HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION
5 0.0000012685 GALLIUM NITRATE//GE 68 GA 68 GENERATOR//GALLIUM 68
6 0.0000010522 RIBOSOME INACTIVATING PROTEINS//RICIN//TRICHOSANTHIN
7 0.0000010231 CA 125//CYFRA 21 1//HE4
8 0.0000008799 CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA
9 0.0000007933 RHENIUMV//TECHNETIUM COMPLEXES//OXORHENIUMV
10 0.0000007608 FCRN//NEONATAL FC RECEPTOR//FC GAMMA RECEPTORS